Rs708113 in WNT3A-WNT9A and hepatocellular carcinoma risk

2021 ◽  
Author(s):  
Felix Stickel ◽  
Jochen Hampe
Keyword(s):  
Hepatocellular Carcinoma ◽  
Carcinoma Risk

scholarly journals A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis

Med ◽  
2021 ◽  
Author(s):  
Naoto Fujiwara ◽  
Masahiro Kobayashi ◽  
Austin J. Fobar ◽  
Ayaka Hoshida ◽  
Cesia A. Marquez ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Fibrosis ◽  
Advanced Liver Fibrosis ◽  
Carcinoma Risk

scholarly journals Sorafenib before liver transplantation for hepatocellular carcinoma: risk or give up

2011 ◽  
Vol 24 (11) ◽  
pp. e97-e97 ◽  
Author(s):  
Fabrizio Di Benedetto ◽  
Giuseppe Tarantino ◽  
Roberto Montalti ◽  
Roberto Ballarin ◽  
Giuseppe D’Amico ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Carcinoma Risk

Genetic polymorphisms in DNA repair genes and hepatocellular carcinoma risk

DNA Repair ◽  
2021 ◽  
pp. 103196
Author(s):  
Hossein Ghaderi-Zefrehi ◽  
Maryam Rezaei ◽  
Farzin Sadeghi ◽  
Mohammad Heiat
Keyword(s):  
Hepatocellular Carcinoma ◽  
Dna Repair ◽  
Genetic Polymorphisms ◽  
Dna Repair Genes ◽  
Repair Genes ◽  
Carcinoma Risk

scholarly journals Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels

2015 ◽  
Vol 30 (11) ◽  
pp. 1618 ◽  
Author(s):  
Junggyu Lee ◽  
Dong Hyun Sinn ◽  
Jung Hee Kim ◽  
Geum-Youn Gwak ◽  
Hye Seung Kim ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hbv Dna ◽  
Serum Aminotransferase ◽  
Compensated Cirrhosis ◽  
Carcinoma Risk
Sign in / Sign up

Export Citation Format

Share Document